+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Inflammation Drug"

From
From
From
From
From
Systemic Lupus Erythematosus Drugs Market 2025-2033 - Product Thumbnail Image

Systemic Lupus Erythematosus Drugs Market 2025-2033

  • Report
  • March 2025
  • 144 Pages
  • Global
From
Autoimmune Gastrointestinal Dysmotility Market Report 2025 - Product Thumbnail Image

Autoimmune Gastrointestinal Dysmotility Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
From
From
From
From
Ibuprofen Arginine API Market - Global Forecast to 2030 - Product Thumbnail Image

Ibuprofen Arginine API Market - Global Forecast to 2030

  • Report
  • August 2025
  • 194 Pages
  • Global
From
From
From
From
From
Periodontal Inflammation - Pipeline Insight, 2025 - Product Thumbnail Image

Periodontal Inflammation - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Immune Disorders Drugs market is composed of drugs used to treat a variety of conditions related to the immune system. These drugs are used to treat autoimmune diseases, allergies, and other conditions that affect the body's ability to fight off infection. Inflammation drugs are a subset of these drugs, used to reduce inflammation and swelling caused by an immune response. These drugs can be used to treat a variety of conditions, including rheumatoid arthritis, psoriasis, and Crohn's disease. They can also be used to reduce the risk of infection in patients with weakened immune systems. Inflammation drugs are typically administered orally or intravenously, and can be taken as a single dose or as part of a longer-term treatment plan. Common side effects of these drugs include nausea, vomiting, and diarrhea. Companies in the Immune Disorders Drugs market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more